{"id":2509,"date":"2025-03-13T15:27:20","date_gmt":"2025-03-13T15:27:20","guid":{"rendered":"https:\/\/smaac.dev\/biomedx\/?page_id=2509"},"modified":"2025-03-19T05:01:14","modified_gmt":"2025-03-19T05:01:14","slug":"faqs","status":"publish","type":"page","link":"https:\/\/smaac.dev\/biomedx\/faqs\/","title":{"rendered":"FAQs"},"content":{"rendered":"<div id=\"faqs\" class=\"fusion-container-anchor\"><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:120px;--awb-padding-right:50px;--awb-padding-bottom:50px;--awb-padding-left:50px;--awb-padding-top-medium:50px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1365px;margin-left: calc(-5% \/ 2 );margin-right: calc(-5% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_4 1_4 fusion-flex-column fusion-no-small-visibility\" style=\"--awb-bg-size:cover;--awb-width-large:25%;--awb-margin-top-large:0px;--awb-spacing-right-large:9.5%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:9.5%;--awb-width-medium:25%;--awb-order-medium:0;--awb-spacing-right-medium:9.5%;--awb-spacing-left-medium:9.5%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:2.375%;--awb-spacing-left-small:2.375%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-four\" style=\"--awb-text-color:var(--awb-color5);--awb-margin-bottom:20px;--awb-font-size:3.5em;\"><h4 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;font-size:1em;\"><strong>FAQs<\/strong><\/h4><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_3_4 3_4 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:75%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.1666666666667%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.1666666666667%;--awb-width-medium:75%;--awb-order-medium:0;--awb-spacing-right-medium:3.1666666666667%;--awb-spacing-left-medium:3.1666666666667%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:2.375%;--awb-spacing-left-small:2.375%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"accordian fusion-accordian\" style=\"--awb-padding-top:20px;--awb-padding-bottom:20px;--awb-border-size:1px;--awb-icon-size:12px;--awb-content-font-size:15px;--awb-content-letter-spacing:0.020em;--awb-content-line-height:1.5;--awb-icon-alignment:left;--awb-hover-color:var(--awb-color2);--awb-border-color:var(--awb-color3);--awb-background-color:var(--awb-color1);--awb-divider-color:var(--awb-color4);--awb-divider-hover-color:var(--awb-color4);--awb-icon-color:var(--awb-color8);--awb-title-color:var(--awb-custom_color_1);--awb-content-color:rgba(31,35,41,0.71);--awb-icon-box-color:var(--awb-color8);--awb-toggle-hover-accent-color:var(--awb-color5);--awb-title-font-family:&quot;Plus Jakarta Sans&quot;;--awb-title-font-weight:800;--awb-title-font-style:normal;--awb-title-letter-spacing:0.030em;--awb-content-font-family:var(--awb-typography4-font-family);--awb-content-font-weight:var(--awb-typography4-font-weight);--awb-content-font-style:var(--awb-typography4-font-style);\"><div class=\"panel-group fusion-toggle-icon-unboxed\" id=\"accordion-2509-1\"><div class=\"fusion-panel panel-default panel-d3fcfd8ce56061d32 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_d3fcfd8ce56061d32\"><a aria-expanded=\"false\" aria-controls=\"d3fcfd8ce56061d32\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#d3fcfd8ce56061d32\" href=\"#d3fcfd8ce56061d32\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What is the core scientific principle behind T-FINDER?<\/span><\/a><\/h4><\/div><div id=\"d3fcfd8ce56061d32\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_d3fcfd8ce56061d32\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>The T-FINDER platform is designed to functionally identify and map cognate epitopes to human T cell receptors (TCRs) with high speed and accuracy. It utilizes physiological antigen processing and T-cell activation processes.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-d863d1cbceb0f41c9 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_d863d1cbceb0f41c9\"><a aria-expanded=\"false\" aria-controls=\"d863d1cbceb0f41c9\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#d863d1cbceb0f41c9\" href=\"#d863d1cbceb0f41c9\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What problem does T-FINDER solve that existing technologies cannot?<\/span><\/a><\/h4><\/div><div id=\"d863d1cbceb0f41c9\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_d863d1cbceb0f41c9\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Traditional methods often rely on engineered variants of TCRs and peptide:HLA complexes, prior knowledge of epitopes, or predictive tools based on flawed, biased, or incomplete data sets. T-FINDER can identify TCR:target interactions de novo and is internally validating, meaning that while it is compatible with other approaches, it is not dependent on them. This overcomes the limitations of fully cataloging TCR interactions.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-e7b87e47d90bff447 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_e7b87e47d90bff447\"><a aria-expanded=\"false\" aria-controls=\"e7b87e47d90bff447\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#e7b87e47d90bff447\" href=\"#e7b87e47d90bff447\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What are the unique features or innovations of T-FINDER compared to competitors?<\/span><\/a><\/h4><\/div><div id=\"e7b87e47d90bff447\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_e7b87e47d90bff447\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>\u00a0High physiological relevance<\/li>\n<li>Agnostic and unbiased HLA coverage of both class I and class II alleles<\/li>\n<li>Ability to process long open reading frames (up to 400 amino acids) for comprehensive proteome coverage via epitope multiplexing<\/li>\n<li>Best-in-class signal-to-noise ratio for a TCR signaling reporter<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-da21ad929e27d4b9c fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_da21ad929e27d4b9c\"><a aria-expanded=\"false\" aria-controls=\"da21ad929e27d4b9c\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#da21ad929e27d4b9c\" href=\"#da21ad929e27d4b9c\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Can you provide a step-by-step explanation of how the platform works?<\/span><\/a><\/h4><\/div><div id=\"da21ad929e27d4b9c\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_da21ad929e27d4b9c\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>TCR, CAR, or similar T cell-activating receptors of interest are inserted into the T cell reporter line, which signals activation via fluorescence and secretes a label to tag antigen-presenting cells (APCs).<\/li>\n<li>Primary APCs (autologous or from a haplotyped biobank, or alternatives such as cancer cell lines or engineered APCs) process and present antigens from a library of putative targets, covering a broad range of epitopes and HLA alleles.<\/li>\n<li>Flexible throughput of combinatorial approach can functionally interrogate up to 20k potential TCR:ligand interactions per month, allowing for TCR-side and\/or ligand-side library scaling.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-6f49905c058f89ea0 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_6f49905c058f89ea0\"><a aria-expanded=\"false\" aria-controls=\"6f49905c058f89ea0\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#6f49905c058f89ea0\" href=\"#6f49905c058f89ea0\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Who are the primary users of T-FINDER?<\/span><\/a><\/h4><\/div><div id=\"6f49905c058f89ea0\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_6f49905c058f89ea0\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Researchers in oncology, autoimmunity, infectious diseases, and drug discovery<\/li>\n<li>Biopharma companies developing TCR\/CAR-T cell therapies, tumor vaccines, and antigen-specific immunomodulation<\/li>\n<li>Academic immunologists investigating TCR functionality and adaptive immune responses in any field<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-5ed43bde2fef480e5 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_5ed43bde2fef480e5\"><a aria-expanded=\"false\" aria-controls=\"5ed43bde2fef480e5\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#5ed43bde2fef480e5\" href=\"#5ed43bde2fef480e5\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What challenges do potential customers face in TCR:ligand mapping today?<\/span><\/a><\/h4><\/div><div id=\"5ed43bde2fef480e5\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_5ed43bde2fef480e5\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Current methods often require prior knowledge of epitopes or presenting alleles, limiting discovery scope and accuracy.<\/li>\n<li>High-throughput screening can be noisy and inefficient.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-844e5aa1b933646f7 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_844e5aa1b933646f7\"><a aria-expanded=\"false\" aria-controls=\"844e5aa1b933646f7\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#844e5aa1b933646f7\" href=\"#844e5aa1b933646f7\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What types of projects or research goals are ideal for using T-FINDER?<\/span><\/a><\/h4><\/div><div id=\"844e5aa1b933646f7\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_844e5aa1b933646f7\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>\u00a0Projects requiring TCR discovery, epitope mapping, or functional validation<\/li>\n<li>Research into tumor vaccines, autoantigen discovery, and infectious disease etiology and therapies<\/li>\n<li>Safety assessments and immunogenicity profiling<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-9f89226563ecbf288 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_9f89226563ecbf288\"><a aria-expanded=\"false\" aria-controls=\"9f89226563ecbf288\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#9f89226563ecbf288\" href=\"#9f89226563ecbf288\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What are the main applications of T-FINDER?<\/span><\/a><\/h4><\/div><div id=\"9f89226563ecbf288\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_9f89226563ecbf288\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>TCR discovery and characterization<\/li>\n<li>Validation of TCR:epitope interactions<\/li>\n<li>Functional epitope mapping<\/li>\n<li>CAR-T evaluation<\/li>\n<li>Safety profiling of TCR-based therapies<\/li>\n<li><i>De novo<\/i> TCR ligand identification<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-46351b85b4a091dde fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_46351b85b4a091dde\"><a aria-expanded=\"false\" aria-controls=\"46351b85b4a091dde\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#46351b85b4a091dde\" href=\"#46351b85b4a091dde\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What measurable benefits does T-FINDER provide?<\/span><\/a><\/h4><\/div><div id=\"46351b85b4a091dde\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_46351b85b4a091dde\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>High speed and precision in mapping TCR:ligand interactions<\/li>\n<li>Broad epitope and HLA coverage for comprehensive profiling<\/li>\n<li>Cost-efficient functional screening with reduced noise<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-a0bad0dc5aba64452 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_a0bad0dc5aba64452\"><a aria-expanded=\"false\" aria-controls=\"a0bad0dc5aba64452\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#a0bad0dc5aba64452\" href=\"#a0bad0dc5aba64452\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What differentiates T-FINDER from other TCR-ligand mapping solutions?<\/span><\/a><\/h4><\/div><div id=\"a0bad0dc5aba64452\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_a0bad0dc5aba64452\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>\u00a0It leverages physiological antigen processing and presentation, overcoming limitations of engineered or peptide-loading approaches.<\/li>\n<li>It supports high-throughput yet precise screening with advanced sequencing and combinatorial methods.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-8d7bd76d751d36b16 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_8d7bd76d751d36b16\"><a aria-expanded=\"false\" aria-controls=\"8d7bd76d751d36b16\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#8d7bd76d751d36b16\" href=\"#8d7bd76d751d36b16\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What is our unique value proposition compared to other tools?<\/span><\/a><\/h4><\/div><div id=\"8d7bd76d751d36b16\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_8d7bd76d751d36b16\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Physiological relevance, functional validation, agnostic HLA allele coverage, class II HLA-presented epitope identification, scalability, and precision in identifying TCR:ligand interactions<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-3cd12ba8bee00dd76 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_3cd12ba8bee00dd76\"><a aria-expanded=\"false\" aria-controls=\"3cd12ba8bee00dd76\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#3cd12ba8bee00dd76\" href=\"#3cd12ba8bee00dd76\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What publications support T-FINDER\u2019s credibility?<\/span><\/a><\/h4><\/div><div id=\"3cd12ba8bee00dd76\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_3cd12ba8bee00dd76\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Two publications in <i>Science Advances<\/i> describe the platform&#8217;s efficacy in functional TCR and ligand discovery.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-71a3bc0417ce5dc9e fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_71a3bc0417ce5dc9e\"><a aria-expanded=\"false\" aria-controls=\"71a3bc0417ce5dc9e\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#71a3bc0417ce5dc9e\" href=\"#71a3bc0417ce5dc9e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What are example workflows for a customer using T-FINDER?<\/span><\/a><\/h4><\/div><div id=\"71a3bc0417ce5dc9e\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_71a3bc0417ce5dc9e\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>\u00a0A fee-for-service model where customers define their research objectives, and BioMed X delivers tailored TCR:ligand mapping results<\/li>\n<li>Up-front payment in which customers gain full ownership of the results without royalty obligations<\/li>\n<li>Supported discovery research sponsorship with right-to-first-refusal of the results upon project completion<\/li>\n<li>Asset development program in which a disease modality is indicated by the customer and BioMed X delivers a series of TCR sequences with identified targets for cellular therapies<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-1fda658c0f774eca3 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_1fda658c0f774eca3\"><a aria-expanded=\"false\" aria-controls=\"1fda658c0f774eca3\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#1fda658c0f774eca3\" href=\"#1fda658c0f774eca3\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What training or support is needed for customers to use the platform effectively?<\/span><\/a><\/h4><\/div><div id=\"1fda658c0f774eca3\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_1fda658c0f774eca3\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>No customer-side operation beyond the scientific vision is required; the platform operates as a service, with BioMed X handling the technical aspects.<\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-bf807563e86dd0f81 fusion-toggle-has-divider\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_bf807563e86dd0f81\"><a aria-expanded=\"false\" aria-controls=\"bf807563e86dd0f81\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-2509-1\" data-target=\"#bf807563e86dd0f81\" href=\"#bf807563e86dd0f81\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon awb-icon-plus\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What feedback have you received from customers or collaborators so far?<\/span><\/a><\/h4><\/div><div id=\"bf807563e86dd0f81\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_bf807563e86dd0f81\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li>Publications and ongoing collaborations support further adoption of the platform, with demonstrated successes in tumor neoepitope identification and personalized therapy development.<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2407,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-2509","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/pages\/2509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/comments?post=2509"}],"version-history":[{"count":4,"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/pages\/2509\/revisions"}],"predecessor-version":[{"id":2634,"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/pages\/2509\/revisions\/2634"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/media\/2407"}],"wp:attachment":[{"href":"https:\/\/smaac.dev\/biomedx\/wp-json\/wp\/v2\/media?parent=2509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}